CRY2 Antibody (YA7011)

CRY2 (Cryptochrome Circadian Regulator 2) is a flavin adenine dinucleotide (FAD) -binding core component of the mammalian circadian oscillator that participates in the transcription-translation negative feedback loop controlling circadian rhythmicity^[1][2]. CRY2 is transcriptionally activated by the CLOCK:BMAL1 complex and subsequently represses CLOCK:BMAL1-dependent gene expression through PER/CRY-mediated feedback regulation, thereby maintaining circadian clock function and physiological timing programs^[1][3]. Mechanistically, CRY2 functions as a transcriptional repressor within large PER-CRY complexes, regulating rhythmic processes linked to metabolism, sleep-wake cycles, and tissue-specific clock outputs^[2][3]. In disease-relevant and experimental models, disruption of CRY2 activity has been associated with altered sleep patterns, metabolic regulation, cognitive decline following sleep deprivation, and circadian dysfunction, supporting its importance in physiological and pathological clock regulation^[1][4]. Compared with the closely related isoform CRY1, CRY2 exhibits weaker repression of CLOCK:BMAL1 and displays distinct structural and biochemical properties that contribute to differential circadian period regulation^[2][5]. Structural studies demonstrated that differences within the FAD-binding pocket, lid loop, secondary pocket, and serine loop influence protein interactions and underlie isoform-selective regulatory mechanisms between CRY1 and CRY2^[2][5]. Therefore, CRY2 has become an important target for chemical biology and circadian research, where structural insights are guiding the development of small-molecule modulators and isoform-selective compounds for mechanistic studies of clock-associated biological processes and diseases^[2][6].